Associated Alcohols & Breweries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 13, 2025, 4:14 am

Quick Insight

Associated Alcohols & Breweries Ltd, operating in the Beverages & Distilleries industry, shows a strong intrinsic value with a share price of 1,040 and a market cap of 1,996 Cr. The company's P/E ratio stands at 22.8, indicating a favorable valuation. With a ROE of 17.3% and ROCE of 20.0%, it displays efficient capital utilization. The OPM at 14% reflects decent operational efficiency. Notably, the company's robust net profit of 81 Cr. is supported by healthy reserves of 502 Cr. and manageable borrowings of 102 Cr. The diversified shareholding pattern, with promoters holding a significant stake at 59.29%, adds to investor confidence. Overall, these metrics suggest a financially stable company with growth potential in the industry.

Competitors of Associated Alcohols & Breweries Ltd

All Competitor Stocks of Associated Alcohols & Breweries Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:25 pm

Below is a detailed analysis of the quarterly data for Associated Alcohols & Breweries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 267.00 Cr.. The value appears strong and on an upward trend. It has increased from 242.00 Cr. (Mar 2025) to 267.00 Cr., marking an increase of 25.00 Cr..
• For Expenses, as of Jun 2025, the value is 230.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 207.00 Cr. (Mar 2025) to 230.00 Cr., marking an increase of 23.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 37.00 Cr.. The value appears strong and on an upward trend. It has increased from 35.00 Cr. (Mar 2025) to 37.00 Cr., marking an increase of 2.00 Cr..
• For OPM %, as of Jun 2025, the value is 14.00%. The value appears to be declining and may need further review. It has decreased from 15.00% (Mar 2025) to 14.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 2.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 2.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 12.34. The value appears strong and on an upward trend. It has increased from 11.64 (Mar 2025) to 12.34, marking an increase of 0.70.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 5:24 pm

Growth

Last Updated: September 4, 2025, 11:55 pm

Balance Sheet

Last Updated: May 13, 2025, 3:51 pm

Below is a detailed analysis of the balance sheet data for Associated Alcohols & Breweries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 18.00 Cr..
• For Reserves, as of Mar 2025, the value is 502.00 Cr.. The value appears strong and on an upward trend. It has increased from 405.00 Cr. (Mar 2024) to 502.00 Cr., marking an increase of 97.00 Cr..
• For Borrowings, as of Mar 2025, the value is 102.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 108.00 Cr. (Mar 2024) to 102.00 Cr., marking a decrease of 6.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 96.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 88.00 Cr. (Mar 2024) to 96.00 Cr., marking an increase of 8.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 718.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 619.00 Cr. (Mar 2024) to 718.00 Cr., marking an increase of 99.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 351.00 Cr.. The value appears strong and on an upward trend. It has increased from 252.00 Cr. (Mar 2024) to 351.00 Cr., marking an increase of 99.00 Cr..
• For CWIP, as of Mar 2025, the value is 32.00 Cr.. The value appears to be declining and may need further review. It has decreased from 63.00 Cr. (Mar 2024) to 32.00 Cr., marking a decrease of 31.00 Cr..
• For Investments, as of Mar 2025, the value is 64.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2024) to 64.00 Cr., marking an increase of 18.00 Cr..
• For Other Assets, as of Mar 2025, the value is 271.00 Cr.. The value appears strong and on an upward trend. It has increased from 257.00 Cr. (Mar 2024) to 271.00 Cr., marking an increase of 14.00 Cr..
• For Total Assets, as of Mar 2025, the value is 718.00 Cr.. The value appears strong and on an upward trend. It has increased from 619.00 Cr. (Mar 2024) to 718.00 Cr., marking an increase of 99.00 Cr..

Notably, the Reserves (502.00 Cr.) exceed the Borrowings (102.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Associated Alcohols & Breweries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 28.00. This value is within the healthy range. It has increased from 22.99 (Mar 23) to 28.00, marking an increase of 5.01.
• For Diluted EPS (Rs.), as of Mar 24, the value is 28.00. This value is within the healthy range. It has increased from 22.99 (Mar 23) to 28.00, marking an increase of 5.01.
• For Cash EPS (Rs.), as of Mar 24, the value is 35.97. This value is within the healthy range. It has increased from 30.94 (Mar 23) to 35.97, marking an increase of 5.03.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 233.89. It has increased from 201.01 (Mar 23) to 233.89, marking an increase of 32.88.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 233.89. It has increased from 201.01 (Mar 23) to 233.89, marking an increase of 32.88.
• For Dividend / Share (Rs.), as of Mar 24, the value is 2.00. This value is within the healthy range. It has increased from 1.00 (Mar 23) to 2.00, marking an increase of 1.00.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 420.26. It has increased from 387.61 (Mar 23) to 420.26, marking an increase of 32.65.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 47.77. This value is within the healthy range. It has increased from 39.43 (Mar 23) to 47.77, marking an increase of 8.34.
• For PBIT / Share (Rs.), as of Mar 24, the value is 39.80. This value is within the healthy range. It has increased from 31.47 (Mar 23) to 39.80, marking an increase of 8.33.
• For PBT / Share (Rs.), as of Mar 24, the value is 37.77. This value is within the healthy range. It has increased from 30.69 (Mar 23) to 37.77, marking an increase of 7.08.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 28.00. This value is within the healthy range. It has increased from 22.98 (Mar 23) to 28.00, marking an increase of 5.02.
• For PBDIT Margin (%), as of Mar 24, the value is 11.36. This value is within the healthy range. It has increased from 10.17 (Mar 23) to 11.36, marking an increase of 1.19.
• For PBIT Margin (%), as of Mar 24, the value is 9.47. This value is below the healthy minimum of 10. It has increased from 8.11 (Mar 23) to 9.47, marking an increase of 1.36.
• For PBT Margin (%), as of Mar 24, the value is 8.98. This value is below the healthy minimum of 10. It has increased from 7.91 (Mar 23) to 8.98, marking an increase of 1.07.
• For Net Profit Margin (%), as of Mar 24, the value is 6.66. This value is within the healthy range. It has increased from 5.93 (Mar 23) to 6.66, marking an increase of 0.73.
• For Return on Networth / Equity (%), as of Mar 24, the value is 11.97. This value is below the healthy minimum of 15. It has increased from 11.43 (Mar 23) to 11.97, marking an increase of 0.54.
• For Return on Capital Employeed (%), as of Mar 24, the value is 14.84. This value is within the healthy range. It has increased from 12.94 (Mar 23) to 14.84, marking an increase of 1.90.
• For Return On Assets (%), as of Mar 24, the value is 8.18. This value is within the healthy range. It has increased from 7.72 (Mar 23) to 8.18, marking an increase of 0.46.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.11. This value is below the healthy minimum of 0.2. It has decreased from 0.18 (Mar 23) to 0.11, marking a decrease of 0.07.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.24. This value is within the healthy range. It has decreased from 0.26 (Mar 23) to 0.24, marking a decrease of 0.02.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.31. It has decreased from 1.49 (Mar 23) to 1.31, marking a decrease of 0.18.
• For Current Ratio (X), as of Mar 24, the value is 1.75. This value is within the healthy range. It has decreased from 2.48 (Mar 23) to 1.75, marking a decrease of 0.73.
• For Quick Ratio (X), as of Mar 24, the value is 0.96. This value is below the healthy minimum of 1. It has decreased from 1.62 (Mar 23) to 0.96, marking a decrease of 0.66.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.58. This value is within the healthy range. It has decreased from 5.12 (Mar 23) to 4.58, marking a decrease of 0.54.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 3.57. This value is below the healthy minimum of 20. It has decreased from 4.35 (Mar 23) to 3.57, marking a decrease of 0.78.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 2.78. This value is below the healthy minimum of 20. It has decreased from 3.23 (Mar 23) to 2.78, marking a decrease of 0.45.
• For Earning Retention Ratio (%), as of Mar 24, the value is 96.43. This value exceeds the healthy maximum of 70. It has increased from 95.65 (Mar 23) to 96.43, marking an increase of 0.78.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 97.22. This value exceeds the healthy maximum of 70. It has increased from 96.77 (Mar 23) to 97.22, marking an increase of 0.45.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 23.52. This value is within the healthy range. It has decreased from 50.23 (Mar 23) to 23.52, marking a decrease of 26.71.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 14.78. This value is within the healthy range. It has decreased from 30.28 (Mar 23) to 14.78, marking a decrease of 15.50.
• For Enterprise Value (Cr.), as of Mar 24, the value is 914.06. It has increased from 616.81 (Mar 23) to 914.06, marking an increase of 297.25.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.20. This value is within the healthy range. It has increased from 0.88 (Mar 23) to 1.20, marking an increase of 0.32.
• For EV / EBITDA (X), as of Mar 24, the value is 10.58. This value is within the healthy range. It has increased from 8.65 (Mar 23) to 10.58, marking an increase of 1.93.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.12. This value is within the healthy range. It has increased from 0.83 (Mar 23) to 1.12, marking an increase of 0.29.
• For Retention Ratios (%), as of Mar 24, the value is 96.42. This value exceeds the healthy maximum of 70. It has increased from 95.64 (Mar 23) to 96.42, marking an increase of 0.78.
• For Price / BV (X), as of Mar 24, the value is 2.01. This value is within the healthy range. It has increased from 1.61 (Mar 23) to 2.01, marking an increase of 0.40.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.12. This value is within the healthy range. It has increased from 0.83 (Mar 23) to 1.12, marking an increase of 0.29.
• For EarningsYield, as of Mar 24, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 23) to 0.05, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness